HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maxime Breban Selected Research

Cathepsin H

1/2013ImmunoChip study implicates antigen presentation to T cells in narcolepsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maxime Breban Research Topics

Disease

17Ankylosing Spondylitis
01/2020 - 09/2002
9Spondylarthropathies
01/2016 - 03/2002
8Inflammation (Inflammations)
01/2021 - 03/2003
7Axial Spondyloarthritis
01/2022 - 07/2014
6Back Pain (Backache)
01/2021 - 08/2011
5Psoriatic Arthritis
01/2016 - 09/2002
5Arthritis (Polyarthritis)
05/2015 - 02/2004
4Uveitis
01/2016 - 04/2004
3Pain (Aches)
01/2022 - 03/2002
3Genetic Predisposition to Disease (Genetic Predisposition)
01/2021 - 07/2006
2Dysbiosis
07/2022 - 01/2021
2Colitis
01/2021 - 10/2012
2Spondylarthritis (Spinal Arthritis)
10/2012 - 07/2007
2Latent Tuberculosis
12/2007 - 01/2006
2Rheumatoid Arthritis
11/2006 - 01/2006
2Necrosis
01/2006 - 09/2002
2Crohn Disease (Crohn's Disease)
01/2006 - 10/2003
1Fatigue
01/2022
1Sepsis (Septicemia)
01/2021
1COVID-19
01/2021
1Endotoxemia
01/2021
1Dacryocystitis (Dacryoadenitis)
01/2018
1Adult-Onset Still's Disease
01/2018
1Basal Cell Carcinoma (Rodent Ulcer)
03/2016
1Reinfection
03/2016
1Subacute Thyroiditis (Thyroiditis, De Quervain)
01/2016
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2015
1Disease Progression
06/2015
1Bone Resorption
06/2015
1Serum Sickness
06/2013
1Sjogren's Syndrome (Sjogren Syndrome)
06/2013
1Psoriasis (Pustulosis Palmaris et Plantaris)
04/2013
1Enthesopathy
04/2013
1Narcolepsy
01/2013
1Arthralgia (Joint Pain)
12/2012
1B-Cell Lymphoma (Lymphoma, B Cell)
03/2008
1Lymphoma (Lymphomas)
03/2008
1Disease Susceptibility (Diathesis)
07/2007
1Infections
01/2006
1Rheumatic Diseases (Rheumatism)
04/2005
1Ulcerative Colitis
11/2003
1Tuberculosis (Tuberculoses)
10/2003
1Atrophy
03/2003
1Achlorhydria (Hypochlorhydria)
03/2003
1Neoplasms (Cancer)
03/2003
1Gastritis
03/2003
1Atrophic Gastritis
03/2003
1Synovitis
09/2002

Drug/Important Bio-Agent (IBA)

16HLA-B27 Antigen (HLA B27 Antigen)IBA
07/2022 - 02/2004
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 03/2003
6Infliximab (Remicade)FDA Link
03/2016 - 03/2002
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2022 - 11/2003
3Pharmaceutical PreparationsIBA
01/2021 - 09/2015
3CytokinesIBA
01/2021 - 03/2003
3AntigensIBA
01/2021 - 05/2007
3Peptides (Polypeptides)IBA
01/2020 - 02/2004
3Interleukin-1 (Interleukin 1)IBA
01/2018 - 07/2006
3O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA
01/2016 - 12/2012
3HLA-B Antigens (HLA-B)IBA
05/2015 - 08/2011
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2021 - 01/2020
2InterleukinsIBA
01/2021 - 03/2003
2Biomarkers (Surrogate Marker)IBA
11/2017 - 01/2017
2DNA (Deoxyribonucleic Acid)IBA
01/2017 - 03/2003
2Proteins (Proteins, Gene)FDA Link
07/2007 - 03/2003
1Janus Kinase InhibitorsIBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2021
1Antirheumatic Agents (DMARD)IBA
01/2021
1Biological ProductsIBA
01/2016
1Tumor Necrosis Factor InhibitorsIBA
09/2015
1Adalimumab (Humira)FDA Link
07/2015
1AminopeptidasesIBA
07/2013
1Rituximab (Mabthera)FDA Link
06/2013
1Prostaglandins AIBA
04/2013
1C-Reactive ProteinIBA
04/2013
1CholesterolIBA
04/2013
1Triglycerides (Triacylglycerol)IBA
04/2013
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2013
1OX40 LigandIBA
01/2013
1Cathepsin HIBA
01/2013
1OrexinsIBA
01/2013
1Etanercept (Enbrel)FDA Link
03/2008
1Tuberculin (PPD)IBA
12/2007
1HLA-B*07:02 antigenIBA
07/2007
1HLA-B*27:05 antigenIBA
07/2007
1HLA-B*27:09 antigenIBA
07/2007
1ClusterinIBA
11/2006
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
11/2003
1Therapeutic UsesIBA
10/2003
1Messenger RNA (mRNA)IBA
10/2003
1Free RadicalsIBA
03/2003
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
03/2003
1AcidsIBA
03/2003
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2003
1Virulence Factors (Pathogenicity Factors)IBA
03/2003
1GastrinsIBA
03/2003

Therapy/Procedure

7Therapeutics
03/2016 - 09/2002
1Drug Therapy (Chemotherapy)
01/2022
1Biological Therapy
01/2021
1Injections
04/2005